30 Recruiting Refractory Non-Hodgkin Lymphoma Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Browse by Study Phase
Top Recruiting Refractory Non-Hodgkin Lymphoma Studies
🟢 Recruiting Phase1 💊 Investigational Drug / Biologic
Study of SIRPant-M in Participants With Relapsed or Refractory Non-Hodgkin's Lymphoma
📍 City of Hope — Duarte, California
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
CAR-T Cell Therapy, Mosunetuzumab and Polatuzumab for Treatment of Refractory/Relapsed Aggressive Non-Hodgkin's Lymphoma (NHL).
📍 University of Miami — Miami, Florida
View Study & Checklist ➔ 🟢 Recruiting Phase1 💊 Investigational Drug / Biologic
Anti-CD19 Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma
📍 University of California, San Francisco — San Francisco, California
View Study & Checklist ➔